President Donald Trump questioned on Monday why past leader Joe Biden’s cancer wasn’t discovered before it reached an “aggressive” level and whether there was a connection between the cover-up of Biden’s mental decline and his ostensibly delayed cancer treatment.
Trump addressed Biden’s cancer diagnosis to reporters at the White House on Monday, saying it was “very unhappy” and that he was surprised that no one had been “warned a long time” because prostate cancer “goes to stage nine.”
Trump remarked,” If it’s the same physician who said there was nothing wrong it, that’s being proven to be a terrible condition.”
In other words, there are issues happening that the general public wasn’t aware of, Trump added. And I believe that any patient will need to communicate with his doctor, whether it is the same doctor or even if they are two distinct doctors. Why wasn’t the mental ability discussed? I believe the physicians told him he was good, but it turns out that’s not the case. It is a pretty risky situation. This is no more socially right, look. Our nation is at risk from this.
READ MORE: Biden’s diagnosis of “aggressive” cancers
Trump even questioned why it took so long for Biden to be identified with prostate cancer in public when the condition progressed slowly.
Trump told writers,” It can take years to get to this level of danger.” But, look, it’s a very, very terrible situation, and I feel very badly about it, and I think people may try to find out what happened.
Trump continued,” Someone is not disclosing the details.” That is a significant issue.
Multiple medical experts have expressed concerns about the late diagnosis following Biden’s personal office’s announcement on Sunday that the 82-year-old former president had been diagnosed with an “aggressive” form of prostate cancer that was” characterized by a Gleason score of 9 ( Grade Group 5 ) with metastasis to the bone.
According to medical experts, Biden probably had prostate cancer during his name in the White House because it usually takes at least five years for a person to distribute to their bones.
It’s hardly credible that we are hearing about his malignant condition for the first time because he was having trouble urinating and they found it, according to Atossa Genetics CEO Dr. Steven Quay. That simply doesn’t follow.”
